Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial transcriptomics reveals clonal relationships between intraductal carcinoma and adjacent invasive prostate cancer.

Histopathology·2026
Same author

HOOK2 downregulation compromises the tumorigenic and stemness properties of ovarian cancer cells by increasing endoplasmic reticulum stress.

Cell death & disease·2026
Same author

Automated FRAP microscopy for high-throughput analysis of protein dynamics in chromatin organization and transcription.

FEBS open bio·2025
Same author

ZC3H13 Loss Drives Cancer Metastatic Progression by Disrupting m6A RNA Methylation.

Cancer research·2025
Same author

Translon: a single term for translated regions.

Nature methods·2025
Same author

Roadblocks of Urinary EV Biomarkers: Moving Toward the Clinic.

Journal of extracellular vesicles·2025

Related Experiment Video

Updated: Mar 6, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.3K

The Non-Coding Transcriptome of Prostate Cancer: Implications for Clinical Practice.

Irene V Bijnsdorp1, Martin E van Royen2, Gerald W Verhaegh3

  • 1Department of Urology, VU University Medical Center, Amsterdam, The Netherlands.

Molecular Diagnosis & Therapy
|March 17, 2017
PubMed
Summary

Non-coding RNAs (ncRNAs) are increasingly recognized as crucial biomarkers for prostate cancer (PCa) diagnosis and prognosis. This review explores ncRNAs

More Related Videos

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.3K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.2K

Related Experiment Videos

Last Updated: Mar 6, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.3K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.3K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.2K

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Prostate cancer (PCa) is a leading cause of cancer death in men, with unclear molecular mechanisms.
  • Current biomarkers struggle to differentiate indolent from aggressive PCa.
  • Non-coding RNAs (ncRNAs) are a vast, understudied class of molecules with potential diagnostic and prognostic value.

Purpose of the Study:

  • To review the types and functions of ncRNAs.
  • To highlight ncRNAs relevant to PCa diagnosis and prognosis.
  • To discuss the future therapeutic potential of ncRNAs in PCa.

Main Methods:

  • Literature review of ncRNA research in prostate cancer.
  • Analysis of ncRNA expression patterns in PCa.
  • Evaluation of ncRNAs as diagnostic and prognostic biomarkers.

Main Results:

  • ncRNAs exhibit tissue-specific expression and altered patterns in PCa.
  • Specific ncRNAs show promise as biomarkers for PCa diagnosis and prognosis.
  • ncRNAs may serve as therapeutic targets for PCa treatment.

Conclusions:

  • ncRNAs represent a significant area of research for improving PCa management.
  • Further investigation into ncRNAs can lead to novel diagnostic, prognostic, and therapeutic strategies for PCa.
  • ncRNAs hold promise for personalized medicine approaches in prostate cancer care.